BARTOLOMEI, MIRCO
 Distribuzione geografica
Continente #
NA - Nord America 1.127
EU - Europa 447
AS - Asia 245
AF - Africa 3
OC - Oceania 1
Totale 1.823
Nazione #
US - Stati Uniti d'America 1.124
CN - Cina 163
PL - Polonia 141
IT - Italia 120
DE - Germania 36
GB - Regno Unito 34
SE - Svezia 33
TR - Turchia 33
UA - Ucraina 30
BE - Belgio 12
FI - Finlandia 12
IN - India 11
IR - Iran 8
KR - Corea 8
VN - Vietnam 7
FR - Francia 6
HK - Hong Kong 4
ID - Indonesia 4
IE - Irlanda 4
AT - Austria 3
EE - Estonia 3
ES - Italia 3
CA - Canada 2
DK - Danimarca 2
JP - Giappone 2
NL - Olanda 2
PH - Filippine 2
PT - Portogallo 2
RO - Romania 2
ZM - Zambia 2
AU - Australia 1
BG - Bulgaria 1
EG - Egitto 1
IQ - Iraq 1
MX - Messico 1
MY - Malesia 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 1.823
Città #
Chandler 149
Warsaw 136
Fairfield 124
Ashburn 89
Ann Arbor 78
Woodbridge 57
Wilmington 48
Jacksonville 45
Seattle 40
Houston 39
Beijing 34
Izmir 32
Shanghai 32
Ferrara 31
New York 27
Cambridge 25
Addison 23
Nanjing 22
Princeton 21
Dearborn 14
Falls Church 12
Helsinki 12
Milan 12
Boardman 11
Bologna 11
Brussels 11
San Diego 11
Redwood City 10
Bremen 8
Chengdu 8
Nanchang 8
San Mateo 8
Wuhan 8
Augusta 7
Ferrara di Monte Baldo 7
Chongqing 6
Leawood 6
Monmouth Junction 6
Mountain View 6
Ardabil 5
Padova 5
Shenyang 5
Washington 5
Changsha 4
Dong Ket 4
Hong Kong 4
Los Angeles 4
Poggio Renatico 4
Reggio Nell'emilia 4
Tianjin 4
Changchun 3
Hangzhou 3
Jiaxing 3
London 3
Mcallen 3
Mestre 3
Philadelphia 3
Atlanta 2
Chandigarh 2
Chicago 2
Des Moines 2
Ho Chi Minh City 2
Hounslow 2
Kunming 2
Lisbon 2
Norwalk 2
Occhiobello 2
Phoenix 2
Reggio Emilia 2
Taizhou 2
Tappahannock 2
Tartu 2
Treviso 2
Zhengzhou 2
A Coruña 1
Amsterdam 1
Ankara 1
Ashford 1
Bhubaneswar 1
Bischwiller 1
Caerano di San Marco 1
Cheongju-si 1
Cincinnati 1
Copenhagen 1
Craiova 1
Davis 1
Delhi 1
Den Haag 1
Forlì 1
Fremont 1
Fréjus 1
Fuzhou 1
Gent 1
Guangzhou 1
Hanoi 1
Hebei 1
Hull 1
Hyderabad 1
Jinan 1
Kilburn 1
Totale 1.363
Nome #
Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008-2018) (vol 24, 640, 2019) 195
Therapeutic radiometals: Worldwide scientific literature trend analysis (2008–2018) 125
Therapeutic Radiometals: Global Trends Analysis of Scientific Literature (2008 -2018) 117
The impact of FDG and amyloid PET-CT in a clinical setting consisting of patients with suspected dementia: the Ferrara experience 110
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: The role of associated risk factors 91
Comparison of 18F-FDG vs "early phase" 18F-Florbetapir brain distribution in patients with suspected or known neurodegenerative disease 87
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 86
Radioembolisation with 90Y-microspheres: Dosimetric and radiobiological investigation for multi-cycle treatment 78
Automated synthesis of 68Ga-DOTA-TOC with a cationic purification system: Evaluation of methodological and technical aspects in routine preparations 78
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 77
The role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) in suspected recovery of breast cancer disease: comparison with Radiological Imaging and impact on patient management 76
Fractionation of radiopharmaceuticals: set-up and verification of an automatic system portable with integrated dose calibrator 74
Lymphoscintigraphy (LS) of Oral Cavity Cancer (OCC) as tool for surgical customization for a selective and modified lymphadenectomy: preliminary report 74
Technical aspects related to different reconstruction algorithms in FDG PET-CT imaging: a correlation study between SUVmax and volume in neoplastic lesions 69
Impact of (18)F-Fluoro-Methyl-Choline (FMC) PET/CT in the detection of recurrent prostate cancer: correlation with PSA kinetics and Radiological Imaging. 64
Methodology and technical implementation of a procedure for automated production 68Ga-DOTATOC 61
Erratum: Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: The role of associated risk factors 57
Dosimetry for treatment with radiolabelled somatostatin analogues. A review 50
90 Y/177 Lu‐dotatoc From Preclinical Studies to Application in Humans 50
Right Atrium Mass Assessed with 18F-FDG PET/CT Scan Turns Out to Be an Uncommon Relapse of Testicular Diffuse Large B-cell Lymphoma: A Case Report 40
Lymphoscintigraphy and radio-guided neck dissection in oral cavity squamous cell carcinoma 33
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial 22
The Role of [68Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review 21
Rhenium Radioisotopes for Medicine, a Focus on Production and Applications 19
Relevance of Volumetric Parameters Applied to [68Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT 14
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review 13
The Value of Semiquantitative Parameters Derived from 18F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer 13
Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma 12
The Role of [18F]F-Choline PET/CT in the Initial Management and Outcome Prediction of Prostate Cancer: A Real-World Experience from a Multidisciplinary Approach 12
Validation of 99mTc and 177Lu quantification parameters for a Monte Carlo modelled gamma camera 10
18F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes Candidates to Neoadjuvant Chemotherapy 10
Superscan-Like Pattern on 18F-Choline PET/CT in a Patient With Essential Thrombocythemia 10
Misinterpretation of an inflammatory FDG uptake in a patient treated for Hodgkin lymphoma: a case report 6
Localization of Avidin in Superficial Bladder Cancer: A Potentially New Approach for Radionuclide Therapy 6
Comparison of MRI vs. [18F]FDG PET/CT for Treatment Response Evaluation of Primary Breast Cancer after Neoadjuvant Chemotherapy: Literature Review and Future Perspectives 6
Impact on the long-term prognosis of FDG PET/CT in luminal-A and luminal-B breast cancer 6
Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study 5
Incidental findings of acute myeloid leukemia in Sjögren's syndrome detected by nuclear medicine techniques 5
[18F]FDG PET-TC radiomics and machine learning in the evaluation of prostate incidental uptake 5
Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE 5
Lymphoid organs’ metabolism and its role in predicting the outcomes of patients with malignant melanoma treated with immunotherapy: an exploratory study 4
68Ga-PSMA-11 PET/CT in Bilateral Clear Cell Renal Cell Carcinoma: an Intra-patient Comparison Between High and Low Grade Tumors 4
18 F-Choline Versus 68 Ga-PSMA-11 PET/CT Imaging Comparison in Incidental Clear Cell Renal Cell Carcinoma 4
COMPARISON BETWEEN CLINICAL DOSIMETRIC PLATFORMS IN NET PATIENTS TREATED WITH PRRT 3
Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric study 2
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors 2
MONTE CARLO SIMULATIONS IN RADIO-LIGAND THERAPY WITH LU-177 FOR NEUROENDOCRINE TUMOURS (NETS) 1
The Role of Molecular Imaging in Patients with Brain Metastases: A Literature Review 1
Clinical platforms in NET patients treated with radioligand therapy: a dosimetric comparison 1
Totale 1.914
Categoria #
all - tutte 9.399
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.399


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019118 0 0 0 0 0 0 0 0 0 25 22 71
2019/2020318 55 15 15 33 22 41 37 18 23 27 22 10
2020/2021426 17 35 69 61 17 41 22 32 12 34 55 31
2021/2022254 13 16 20 25 19 13 12 19 7 26 12 72
2022/2023358 29 44 9 46 42 40 18 34 38 10 41 7
2023/2024275 18 35 33 14 32 60 10 48 10 15 0 0
Totale 1.914